Document is current
Any future updates will be listed below
-
Authors
Naidoo, Jarushka https://orcid.org/0000-0002-3470-8686
Reuss, Joshua E
Suresh, Karthik
Feller-Kopman, David
Forde, Patrick M
Mehta Steinke, Seema
Rock, Clare
Johnson, Douglas B
Nishino, Mizuki
Brahmer, Julie R
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04244591 at ClinicalTrials.govnct04323592 at ClinicalTrials.govDocuments that mention this clinical trial
Immune-related (IR)-pneumonitis during the COVID-19 pandemic: multidisciplinary recommendations for diagnosis and management
https://doi.org/10.1136/jitc-2020-000984
Drug treatments for covid-19: living systematic review and network meta-analysis
https://doi.org/10.1136/bmj.m2980
nct04273321 at ClinicalTrials.govDocuments that mention this clinical trial
Immune-related (IR)-pneumonitis during the COVID-19 pandemic: multidisciplinary recommendations for diagnosis and management
https://doi.org/10.1136/jitc-2020-000984
nct03601611 at ClinicalTrials.govDocuments that mention this clinical trial
Immune-related (IR)-pneumonitis during the COVID-19 pandemic: multidisciplinary recommendations for diagnosis and management
https://doi.org/10.1136/jitc-2020-000984
Documents that mention this clinical trial
Immune-related (IR)-pneumonitis during the COVID-19 pandemic: multidisciplinary recommendations for diagnosis and management
https://doi.org/10.1136/jitc-2020-000984
COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis
https://doi.org/10.1136/jitc-2022-005111
Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events
https://doi.org/10.1136/jitc-2023-006814
- License Information
